New research suggests that there is an association between thiazolidinediones — a type of drug introduced in the 1990s to treat type 2 diabetes — and bone fracture.
New research suggests that there is an association between thiazolidinediones — a type of drug introduced in the 1990s to treat type 2 diabetes — and bone fracture.